MRI shows periventricular plaques with enhancement after gadolinium
23.1%, relative risk [RR]: 0.39, P = 0.044)
Reported sexual behavior changes tend to follow testosterone shifts and can revert towards baseline if treatment ceases
Dupixent (Dupilumab) Dupixent 2023 Sales: $11.588 billion Company/Developer: Regeneron and Sanofi Date of First FDA Approval: March 28, 2017 Indications Dupixent Is FDA-Approved for: Adults and children six months of age and older with moderate-to-severe eczema (atopic dermatitis or AD)
Hydration is one of the most overlooked but crucial aspects during a weight loss journey, as more people turn to GLP-1 receptor agonists like Mounjaro, Wegovy, or Ozempic
Vision Loss Claims Face Similar Hurdles For NAION cases, the evidentiary burden includes ophthalmology records documenting the sudden vision loss, ruling out other causes, and establishing the timeline between drug use and injury onset